Tuesday 28 December 2010

Palnaxol




Palnaxol may be available in the countries listed below.


Ingredient matches for Palnaxol



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Palnaxol in the following countries:


  • Japan

International Drug Name Search

Sunday 26 December 2010

Venlafaxina Mepha




Venlafaxina Mepha may be available in the countries listed below.


Ingredient matches for Venlafaxina Mepha



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxina Mepha in the following countries:


  • Portugal

International Drug Name Search

Wednesday 22 December 2010

Dysurgal




Dysurgal may be available in the countries listed below.


Ingredient matches for Dysurgal



Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Dysurgal in the following countries:


  • Germany

International Drug Name Search

Tuesday 14 December 2010

Amilo




Amilo may be available in the countries listed below.


Ingredient matches for Amilo



Amlodipine

Amlodipine is reported as an ingredient of Amilo in the following countries:


  • Taiwan

International Drug Name Search

Monday 13 December 2010

Pinavérium Ratiopharm




Pinavérium Ratiopharm may be available in the countries listed below.


Ingredient matches for Pinavérium Ratiopharm



Pinaverium Bromide

Pinaverium Bromide is reported as an ingredient of Pinavérium Ratiopharm in the following countries:


  • France

International Drug Name Search

Friday 10 December 2010

Canadiol




Canadiol may be available in the countries listed below.


Ingredient matches for Canadiol



Itraconazole

Itraconazole is reported as an ingredient of Canadiol in the following countries:


  • Spain

International Drug Name Search

Wednesday 8 December 2010

Damsel




Damsel may be available in the countries listed below.


Ingredient matches for Damsel



Glibenclamide

Glibenclamide is reported as an ingredient of Damsel in the following countries:


  • Japan

International Drug Name Search

Bamipina




Bamipina may be available in the countries listed below.


Ingredient matches for Bamipina



Bamifylline

Bamipina (DCIT) is also known as Bamifylline (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 7 December 2010

Armix




Armix may be available in the countries listed below.


Ingredient matches for Armix



Perindopril

Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Armix in the following countries:


  • Hungary

International Drug Name Search

Monday 6 December 2010

Sultamicilline




Sultamicilline may be available in the countries listed below.


Ingredient matches for Sultamicilline



Sultamicillin

Sultamicilline (DCF) is also known as Sultamicillin (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 5 December 2010

Cétirizine Biogaran




Cétirizine Biogaran may be available in the countries listed below.


Ingredient matches for Cétirizine Biogaran



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cétirizine Biogaran in the following countries:


  • France

International Drug Name Search

Colchicine Actavis




Colchicine Actavis may be available in the countries listed below.


Ingredient matches for Colchicine Actavis



Colchicine

Colchicine is reported as an ingredient of Colchicine Actavis in the following countries:


  • Netherlands

International Drug Name Search

Saturday 4 December 2010

Telkan




Telkan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Telkan



Mebendazole

Mebendazole is reported as an ingredient of Telkan in the following countries:


  • France

International Drug Name Search

Friday 3 December 2010

Opecipro




Opecipro may be available in the countries listed below.


Ingredient matches for Opecipro



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Opecipro in the following countries:


  • Vietnam

International Drug Name Search

Saturday 27 November 2010

Ozagron




Ozagron may be available in the countries listed below.


Ingredient matches for Ozagron



Ozagrel

Ozagrel sodium (a derivative of Ozagrel) is reported as an ingredient of Ozagron in the following countries:


  • Japan

International Drug Name Search

Friday 26 November 2010

Acura




Acura may be available in the countries listed below.


Ingredient matches for Acura



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Acura in the following countries:


  • Sweden

International Drug Name Search

Tuesday 23 November 2010

Opticlox




Opticlox may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Opticlox



Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Opticlox in the following countries:


  • Australia

  • Netherlands

  • United Kingdom

International Drug Name Search

Sunday 14 November 2010

Cefaclor Stada




Cefaclor Stada may be available in the countries listed below.


Ingredient matches for Cefaclor Stada



Cefaclor

Cefaclor is reported as an ingredient of Cefaclor Stada in the following countries:


  • Vietnam

Cefaclor monohydrate (a derivative of Cefaclor) is reported as an ingredient of Cefaclor Stada in the following countries:


  • Germany

International Drug Name Search

Tuesday 9 November 2010

Ketotiphen




Ketotiphen may be available in the countries listed below.


Ingredient matches for Ketotiphen



Ketotifen

Ketotifen is reported as an ingredient of Ketotiphen in the following countries:


  • Georgia

International Drug Name Search

Monday 8 November 2010

Gynol Plus




Gynol Plus may be available in the countries listed below.


Ingredient matches for Gynol Plus



Nonoxinol

Nonoxinol 9 (a derivative of Nonoxinol) is reported as an ingredient of Gynol Plus in the following countries:


  • Iceland

International Drug Name Search

Axotide




Axotide may be available in the countries listed below.


Ingredient matches for Axotide



Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Axotide in the following countries:


  • Switzerland

International Drug Name Search

Thursday 4 November 2010

Tolfenamic Acid




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M01AG02

CAS registry number (Chemical Abstracts Service)

0013710-19-5

Chemical Formula

C14-H12-Cl-N-O2

Molecular Weight

261

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

Benzoic acid, 2-[(3-chloro-2-methylphenyl)amino]-

Foreign Names

  • Acidum tolfenamicum (Latin)
  • Tolfenaminsäure (German)
  • Acide tolfénamique (French)
  • Acido tolfenamico (Spanish)

Generic Names

  • Tolfenamic Acid (OS: JAN, BAN)
  • Acidum tolfenamicum (PH: Ph. Eur. 6)
  • Tolfenamic Acid (PH: BP 2010, Ph. Eur. 6)
  • Tolfenaminsäure (PH: Ph. Eur. 6)
  • Tolfénamique (acide) (PH: Ph. Eur. 6)

Brand Names

  • Clotam
    Faran Laboratories, Greece; Galen, United Kingdom


  • Dolfenax
    Chalver, Colombia; Chalver, Peru


  • Flocur
    Beta, Argentina


  • Gantil
    Elpen, Greece


  • Migea
    Faran Laboratories, Greece; Gea, Poland; Hexal, Czech Republic; Hexal, Norway


  • Polmonin
    Farmanic Chemipharma, Greece


  • Purfalox
    Kleva, Greece


  • Tolfamic
    Mentinova, Greece


  • Tolfedine (veterinary use)
    Ati, Italy; Selecta, Germany; Univete - Técnica Pecuária Comércio e Indústria, Portugal; Vetochas, Germany; Vetoquinol, Austria; Vetoquinol, Belgium; Vetoquinol, Switzerland; Vetoquinol, United Kingdom; Vetoquinol, Ireland; Vetoquinol, Luxembourg; Vetoquinol, Netherlands; Vétoquinol S.A., Australia; Via Vet, Sweden


  • Tolfédine (veterinary use)
    Laboratoire Vétoquinol, France


  • Tolfejec (veterinary use)
    Ilium Veterinary Products, Australia


  • Tolfine (veterinary use)
    Laboratoire Vétoquinol, France; Vetoquinol, Belgium; Vetoquinol, United Kingdom; Vetoquinol, Netherlands


  • Turbaund
    Rafarm, Greece

International Drug Name Search

Glossary

BANBritish Approved Name
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 3 November 2010

Metanor




Metanor may be available in the countries listed below.


Ingredient matches for Metanor



Flupirtine

Flupirtine maleate (a derivative of Flupirtine) is reported as an ingredient of Metanor in the following countries:


  • Portugal

International Drug Name Search

Monday 1 November 2010

Cardopyrin




Cardopyrin may be available in the countries listed below.


Ingredient matches for Cardopyrin



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Cardopyrin in the following countries:


  • Bangladesh

International Drug Name Search

Monday 25 October 2010

Donecil




Donecil may be available in the countries listed below.


Ingredient matches for Donecil



Donepezil

Donepezil is reported as an ingredient of Donecil in the following countries:


  • Peru

International Drug Name Search

Ceftriaxona ICN




Ceftriaxona ICN may be available in the countries listed below.


Ingredient matches for Ceftriaxona ICN



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxona ICN in the following countries:


  • Spain

International Drug Name Search

Sunday 24 October 2010

Corin




Corin may be available in the countries listed below.


Ingredient matches for Corin



Atenolol

Atenolol is reported as an ingredient of Corin in the following countries:


  • Ethiopia

International Drug Name Search

Saturday 23 October 2010

Terbinafine CF




Terbinafine CF may be available in the countries listed below.


Ingredient matches for Terbinafine CF



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbinafine CF in the following countries:


  • Netherlands

International Drug Name Search

Thursday 21 October 2010

Metaciclina




Metaciclina may be available in the countries listed below.


Ingredient matches for Metaciclina



Metacycline

Metaciclina (DCIT) is also known as Metacycline (Prop.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 17 October 2010

Chiari Malformation Medications


There are currently no drugs listed for "Chiari Malformation". See Neurological Disorders.

Definition of Chiari Malformation: Chiari malformations (CMs) are structural defects in the cerebellum, the part of the brain that controls balance. Normally the cerebellum and parts of the brain stem sit in an indented space at the lower rear of the skull, above the foramen magnum (a funnel-like opening to the spinal canal). When part of the cerebellum is located below the foramen magnum, it is called a Chiari malformation.





Drug List:

Thursday 14 October 2010

Colonic Ulceration Medications


There are currently no drugs listed for "Colonic Ulceration". See Gastrointestinal Disorders.

Definition of Colonic Ulceration: Colonic ulceration is the formation of ulcers on the section of the large intestine extending from the cecum to the rectum.





Drug List:

Sunday 10 October 2010

Timolol Ratiopharm




Timolol Ratiopharm may be available in the countries listed below.


Ingredient matches for Timolol Ratiopharm



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Timolol Ratiopharm in the following countries:


  • Netherlands

International Drug Name Search

Oncodria




Oncodria may be available in the countries listed below.


Ingredient matches for Oncodria



Pamidronic Acid

Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Oncodria in the following countries:


  • Colombia

International Drug Name Search

Friday 8 October 2010

Biogesic




Biogesic may be available in the countries listed below.


Ingredient matches for Biogesic



Paracetamol

Paracetamol is reported as an ingredient of Biogesic in the following countries:


  • Indonesia

  • Myanmar

  • Singapore

  • Vietnam

International Drug Name Search

Thursday 7 October 2010

Venlafaxin Krka




Venlafaxin Krka may be available in the countries listed below.


Ingredient matches for Venlafaxin Krka



Venlafaxine

Venlafaxine is reported as an ingredient of Venlafaxin Krka in the following countries:


  • Norway

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxin Krka in the following countries:


  • Sweden

International Drug Name Search

Wednesday 6 October 2010

Chromonar Hydrochloride




Chromonar Hydrochloride may be available in the countries listed below.


Ingredient matches for Chromonar Hydrochloride



Carbocromen

Chromonar Hydrochloride (USAN) is also known as Carbocromen (Rec.INN)

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 4 October 2010

Daktarin Oral




Daktarin Oral may be available in the countries listed below.


Ingredient matches for Daktarin Oral



Miconazole

Miconazole is reported as an ingredient of Daktarin Oral in the following countries:


  • Spain

International Drug Name Search

Tuesday 28 September 2010

Zeda




Zeda may be available in the countries listed below.


Ingredient matches for Zeda



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Zeda in the following countries:


  • Greece

International Drug Name Search

Sunday 26 September 2010

Clarityne




Clarityne may be available in the countries listed below.


Ingredient matches for Clarityne



Loratadine

Loratadine is reported as an ingredient of Clarityne in the following countries:


  • Argentina

  • Bangladesh

  • Chile

  • China

  • Colombia

  • Costa Rica

  • Dominican Republic

  • Ecuador

  • El Salvador

  • France

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Malaysia

  • Mexico

  • Nicaragua

  • Panama

  • Peru

  • Singapore

  • South Africa

  • Spain

  • Taiwan

  • Thailand

  • Venezuela

International Drug Name Search

Loratadina Dany




Loratadina Dany may be available in the countries listed below.


Ingredient matches for Loratadina Dany



Loratadine

Loratadine is reported as an ingredient of Loratadina Dany in the following countries:


  • Peru

International Drug Name Search

Saturday 25 September 2010

Kind Plus




Kind Plus may be available in the countries listed below.


Ingredient matches for Kind Plus



Nimesulide

Nimesulide is reported as an ingredient of Kind Plus in the following countries:


  • India

Paracetamol

Paracetamol is reported as an ingredient of Kind Plus in the following countries:


  • India

International Drug Name Search

Monday 20 September 2010

Osficar




Osficar may be available in the countries listed below.


Ingredient matches for Osficar



Alendronic Acid

Alendronic Acid is reported as an ingredient of Osficar in the following countries:


  • Peru

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Osficar in the following countries:


  • Colombia

  • Guatemala

International Drug Name Search

Friday 10 September 2010

Sensipar


Sensipar is a brand name of cinacalcet, approved by the FDA in the following formulation(s):


SENSIPAR (cinacalcet hydrochloride - tablet; oral)



  • Manufacturer: AMGEN

    Approval date: March 8, 2004

    Strength(s): EQ 30MG BASE, EQ 60MG BASE, EQ 90MG BASE [RLD]

Has a generic version of Sensipar been approved?


No. There is currently no therapeutically equivalent version of Sensipar available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sensipar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Calcium receptor-active molecules
    Patent 6,011,068
    Issued: January 4, 2000
    Inventor(s): Nemeth; Edward F. & Van Wagenen; Bradford C. & Balandrin; Manuel F. & DelMar; Eric G. & Moe; Scott T.
    Assignee(s): NPS Pharmaceuticals, Inc.
    The Brigham and Women's Hospital
    The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules which can modulate one or more inorganic ion receptor activities, preferably the molecule can mimic or block an effect of an extracellular ion on a cell having an inorganic ion receptor, more preferably the extracellular ion is Ca.sup.2+ and the effect is on a cell having a calcium receptor; (2) inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (3) nucleic acids encoding inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (4) antibodies and fragments thereof, targeted to inorganic ion receptor proteins, preferably calcium receptor protein; and (5) uses of such molecules, proteins, nucleic acids and antibodies.
    Patent expiration dates:

    • March 8, 2018
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Calcium receptor-active molecules
    Patent 6,031,003
    Issued: February 29, 2000
    Inventor(s): Nemeth; Edward F. & Van Wagenen; Bradford C. & Balandrin; Manuel F. & DelMar; Eric G. & Moe; Scott T.
    Assignee(s): NPS Pharmaceuticals, Inc.
    The Brigham and Women's Hospital
    The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules which can modulate one or more inorganic ion receptor activities, preferably the molecule can mimic or block an effect of an extracellular ion on a cell having an inorganic ion receptor, more preferably the extracellular ion is Ca.sup.2+ and the effect is on a cell having a calcium receptor; (2) inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (3) nucleic acids encoding inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (4) antibodies and fragments thereof, targeted to inorganic ion receptor proteins, preferably calcium receptor protein; and (5) uses of such molecules, proteins, nucleic acids and antibodies.
    Patent expiration dates:

    • December 14, 2016
      ✓ 
      Patent use: METHOD OF DECREASING OR REDUCING PARATHYROID HORMONE LEVEL; METHOD OF MODULATING PARATHYROID HORMONE SECRETION;METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF REDUCING SERUM IONIZED CALCIUM LEVEL


    • December 14, 2016




  • Calcium receptor-active compounds
    Patent 6,211,244
    Issued: April 3, 2001
    Inventor(s): Van Wagenen; Bradford C. & Moe; Scott T. & Balandrin; Manuel F. & DelMar; Eric G. & Nemeth; Edward F.
    Assignee(s): NPS Pharmaceuticals, Inc.
    The present invention features compounds able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. Preferably, the compound can mimic or block the effect of extracellular Ca.sup.2+ on a calcium receptor.
    Patent expiration dates:

    • October 23, 2015
      ✓ 
      Patent use: METHOD OF DECREASING PARATHYROID HORMONE LEVEL;METHOD OF TREATING HYPERPARATHYROIDISM
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Calcium receptor-active molecules
    Patent 6,313,146
    Issued: November 6, 2001
    Inventor(s): Van Wagenen; Bradford C. & Balandrin; Manuel F. & DelMar; Eric G. & Nemeth; Edward F.
    Assignee(s): NPS Pharmaceuticals, Inc.
    The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules which can modulate one or more inorganic ion receptor activities, preferably the molecule can mimic or block an effect of an extracellular ion on a cell having an inorganic ion receptor, more preferably the extracellular ion is Ca.sup.2+ and the effect is on a cell having a calcium receptor; (2) inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (3) nucleic acids encoding inorganic ion receptor proteins and fragments thereof, preferably calcium receptor proteins and fragments thereof; (4) antibodies and fragments thereof, targeted to inorganic ion receptor proteins, preferably calcium receptor protein; and (5) uses of such molecules, proteins, nucleic acids and antibodies.
    Patent expiration dates:

    • December 14, 2016
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Rapid dissolution formulation of a calcium receptor-active compound
    Patent 7,829,595
    Issued: November 9, 2010
    Inventor(s): Lawrence; Glen Gary & Alvarez; Francisco J. & Lin; Hung-Ren H. & Ju; Tzuchi R.
    Assignee(s): Amgen Inc.
    The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a calcium receptor-active compound and at least one pharmaceutically acceptable excipient, wherein the composition has a controlled dissolution profile. The present invention further relates to a method of manufacturing the pharmaceutical composition, as well as a method of treating a disease using the pharmaceutical composition.
    Patent expiration dates:

    • September 22, 2026
      ✓ 
      Patent use: METHOD OF TREATING HYPERPARATHYROIDISM; METHOD OF TREATING HYPERCALCEMIA
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 8, 2011 - ORPHAN DRUG EXCLUSIVITY

    • February 25, 2014 - TREATMENT OF SEVERE HYPERCALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM WHO ARE UNABLE TO UNDERGO PARATHYROIDECTOMY

    • February 25, 2014 - INCLUSION OF DATA FROM AN ADDITIONAL 19 SUBJECTS WITH HYPERCALCEMIA FROM PARATHYROID CARCINOMA TO THE INFORMATION CURRENTLY PRESENTED IN THE LABEL

    • February 25, 2018 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Sensipar Consumer Information (Drugs.com)
  • Sensipar Consumer Information (Wolters Kluwer)
  • Sensipar Consumer Information (Cerner Multum)
  • Sensipar Advanced Consumer Information (Micromedex)
  • Sensipar AHFS DI Monographs (ASHP)
  • Cinacalcet Consumer Information (Wolters Kluwer)
  • Cinacalcet Consumer Information (Cerner Multum)
  • Cinacalcet Advanced Consumer Information (Micromedex)
  • Cinacalcet AHFS DI Monographs (ASHP)

Temiral




Temiral may be available in the countries listed below.


Ingredient matches for Temiral



Acyclovir

Aciclovir is reported as an ingredient of Temiral in the following countries:


  • Indonesia

International Drug Name Search

Monday 6 September 2010

Omeprazostad




Omeprazostad may be available in the countries listed below.


Ingredient matches for Omeprazostad



Omeprazole

Omeprazole is reported as an ingredient of Omeprazostad in the following countries:


  • Luxembourg

International Drug Name Search

Saturday 4 September 2010

Prazolen




Prazolen may be available in the countries listed below.


Ingredient matches for Prazolen



Omeprazole

Omeprazole is reported as an ingredient of Prazolen in the following countries:


  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Friday 3 September 2010

Oxycodone Hydrochloride




Ingredient matches for Oxycodone Hydrochloride



Oxycodone

Oxycodone Hydrochloride (JAN, USAN) is known as Oxycodone in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 2 September 2010

Iodin




Iodin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Iodin



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Iodin in the following countries:


  • Australia

International Drug Name Search

Thursday 26 August 2010

Cefomit




Cefomit may be available in the countries listed below.


Ingredient matches for Cefomit



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Cefomit in the following countries:


  • Italy

International Drug Name Search

Tuesday 24 August 2010

Orazol




Orazol may be available in the countries listed below.


Ingredient matches for Orazol



Omeprazole

Omeprazole is reported as an ingredient of Orazol in the following countries:


  • Peru

International Drug Name Search

Monday 23 August 2010

Assieme




Assieme may be available in the countries listed below.


Ingredient matches for Assieme



Budesonide

Budesonide is reported as an ingredient of Assieme in the following countries:


  • Italy

Formoterol

Formoterol fumarate (a derivative of Formoterol) is reported as an ingredient of Assieme in the following countries:


  • Italy

International Drug Name Search

Saturday 21 August 2010

Oméprazole Sandoz




Oméprazole Sandoz may be available in the countries listed below.


Ingredient matches for Oméprazole Sandoz



Omeprazole

Omeprazole is reported as an ingredient of Oméprazole Sandoz in the following countries:


  • France

International Drug Name Search

Wednesday 18 August 2010

Cyclopenthiazide




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C03AA07

CAS registry number (Chemical Abstracts Service)

0000742-20-1

Chemical Formula

C13-H18-Cl-N3-O4-S2

Molecular Weight

379

Therapeutic Category

Diuretic agent, benzothiadiazide

Chemical Name

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(cyclopentylmethyl)-3,4-dihydro-, 1,1-dioxide

Foreign Names

  • Cyclopenthiazidum (Latin)
  • Cyclopenthiazid (German)
  • Cyclopenthiazide (French)
  • Ciclopentiazida (Spanish)

Generic Names

  • Cyclopenthiazide (OS: BAN, USAN)
  • Cyclomethiazid (IS)
  • NSC 107679 (IS)
  • Su 8341 (IS)
  • Cyclopenthiazide (PH: BP 2010)

Brand Names

  • Navidrex
    Goldshield, United Kingdom; Novartis, Guyana


  • Navispare (Cyclopenthiazide and Amiloride)
    Goldshield, United Kingdom


  • Trasidrex (Cyclopenthiazide and Oxprenolol)
    Goldshield, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 10 August 2010

Delazinc


Generic Name: zinc oxide topical (ZINK OX ide)

Brand Names: ARC, Balmex, Boudreaux Butt Paste, Caldesene, Calmol-4 Suppository, Critic-Aid Skin Paste, Delazinc, Dermagran BC, Desitin, Desitin Maximum Strength Original, Desitin Rapid Relief Creamy, Diaper Rash Ointment, Diaper Relief, Dr. Smith's Diaper, Flanders Buttocks Ointment, Geri-Protect, Medi-Paste, PeriGuard, Pinxav, Rash Relief, RVPaque, Seniortopix Healix, Soothe & Cool Skin Paste, Sportz Block Dark, Sportz Block Light, Sportz Block Medium, Triple Paste, Tronolane Suppositories, Unna-Flex Elastic Unna Boot 3 inch, Unna-Flex Elastic Unna Boot 4 inch, Znlin


What is Delazinc (zinc oxide topical)?

Zinc oxide is a mineral.


Zinc oxide topical (for the skin) is used to treat diaper rash, minor burns, severely chapped skin, or other minor skin irritations.


Zinc oxide rectal suppositories are used to treat itching, burning, irritation, and other rectal discomfort caused by hemorrhoids or painful bowel movements.


Zinc oxide topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Delazinc (zinc oxide topical)?


You should not use this medication if you are allergic to zinc, dimethicone, lanolin, cod liver oil, petroleum jelly, parabens, mineral oil, or wax.

Zinc oxide topical will not treat a bacterial or fungal infection. Call your doctor if you have any signs of infection such as redness and warmth or oozing skin lesions.


Keep the diaper area clean and dry to prevent worsening of skin rash. Change wet diapers as soon as possible. Allow the skin to dry thoroughly before putting on a fresh diaper.


Stop using this medication and call your doctor if your condition does not improve within 7 days of treatment. Avoid getting this medication in your mouth or eyes. If this does happen, rinse with water right away. Do not use zinc oxide topical on deep skin wounds or severe burns. Get medical attention for more severe skin irritation or injury.

Avoid using other medications on the areas you treat with zinc oxide unless you doctor tells you to.


What should I discuss with my health care provider before using Delazinc (zinc oxide topical)?


You should not use this medication if you are allergic to zinc, dimethicone, lanolin, cod liver oil, petroleum jelly, parabens, mineral oil, or wax.

Zinc oxide topical will not treat a bacterial or fungal infection. Call your doctor if you have any signs of infection such as redness and warmth or oozing skin lesions.


It is not known whether zinc oxide topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether zinc oxide topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without medical advice if you are breast-feeding a baby.

How should I use Delazinc (zinc oxide topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Apply enough of this medication to cover the entire area to be treated. Zinc oxide often leaves a thin white residue that may not be entirely rubbed in.


To treat chapped skin, minor burn wounds, or other skin irritations, use the medication as often as needed. Apply a thin layer to the affected area and rub in gently.


To treat diaper rash, use this medication each time the diaper is changed. It is especially important to apply the medication at bedtime or whenever there will be a long period of time between diaper changes.


Keep the diaper area clean and dry to prevent worsening of skin rash. Change wet diapers as soon as possible. Allow the skin to dry thoroughly before putting on a fresh diaper.


When using the powder form of this medicine, pour the powder slowly to avoid a large puff into the air. Do not allow a baby to handle a powder bottle during use. Always close the lid after using the powder.

Zinc oxide rectal suppositories come with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Wash your hands before and after inserting a rectal suppository.

Try to empty your bowel and bladder just before using the suppository. Cleanse and dry your rectal area thoroughly.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


For best results, stay lying down after inserting the suppository and hold it in your rectum for a few minutes. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in.


Stop using this medication and call your doctor if your condition does not improve within 7 days of treatment. Store at room temperature away from moisture and heat. Keep the tube cap tightly closed when not in use. You may store zinc oxide rectal suppositories in a refrigerator to prevent melting.

What happens if I miss a dose?


Since zinc oxide is used on an as needed basis, you are not likely to miss a dose. Using extra zinc oxide to make up a missed dose will not make the medication more effective.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Delazinc (zinc oxide topical)?


Avoid getting this medication in your mouth or eyes. If this does happen, rinse with water right away. Do not use zinc oxide topical on deep skin wounds or severe burns. Get medical attention for more severe skin irritation or injury.

Delazinc (zinc oxide topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using zinc oxide rectal suppositories if you have rectal bleeding or continued pain.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Delazinc (zinc oxide topical)?


Avoid applying other skin medications on the same treatment area with zinc oxide, unless your doctor has told you to.


There may be other drugs that can interact with zinc oxide topical or rectal suppositories. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Delazinc resources


  • Delazinc Side Effects (in more detail)
  • Delazinc Use in Pregnancy & Breastfeeding
  • Delazinc Support Group
  • 0 Reviews for Delazinc - Add your own review/rating


  • Arcalyst Monograph (AHFS DI)

  • Caldesene Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Desitin Cream MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Delazinc with other medications


  • Anal Itching
  • Dermatologic Lesion


Where can I get more information?


  • Your pharmacist can provide more information about zinc oxide topical.

See also: Delazinc side effects (in more detail)


Monday 9 August 2010

Sertralina Rimafar




Sertralina Rimafar may be available in the countries listed below.


Ingredient matches for Sertralina Rimafar



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Rimafar in the following countries:


  • Spain

International Drug Name Search

Thursday 5 August 2010

Ondansetron Fabra




Ondansetron Fabra may be available in the countries listed below.


Ingredient matches for Ondansetron Fabra



Ondansetron

Ondansetron is reported as an ingredient of Ondansetron Fabra in the following countries:


  • Argentina

International Drug Name Search

Tuesday 27 July 2010

Oxaliplatin Gerolymatos




Oxaliplatin Gerolymatos may be available in the countries listed below.


Ingredient matches for Oxaliplatin Gerolymatos



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatin Gerolymatos in the following countries:


  • Greece

International Drug Name Search

Saturday 24 July 2010

Sulfacetamide




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01AB04

CAS registry number (Chemical Abstracts Service)

0000144-80-9

Chemical Formula

C8-H10-N2-O3-S

Molecular Weight

214

Therapeutic Category

Antibacterial: Sulfonamid

Chemical Name

Acetamide, N-[(4-aminophenyl)sulfonyl]-

Foreign Names

  • Sulfacetamidum (Latin)
  • Sulfacetamid (German)
  • Sulfacétamide (French)
  • Sulfacetamida (Spanish)

Generic Names

  • Sulfacetamide (OS: BAN, DCIT)
  • Sulfacétamide (OS: DCF)
  • Sulfanilazetamid (IS)
  • Sulphacetamide (IS)
  • Sulfacetamide (PH: USP 32, Ph. Int. 4)
  • Sulfacetamidum (PH: Ph. Int. 4)
  • Sulfanilacetamidum (PH: ÖAB 2009)
  • Sulfacetamide Sodium (OS: BANM)
  • Sulfacétamide sodique (PH: Ph. Eur. 6)
  • Sulfacetamide Sodium (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Sulfacetamide, Soluble (PH: BP 2010)
  • Sulfacetamid-Natrium (PH: Ph. Eur. 6)
  • Sulfacetamidum natricum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Fludroxyl (Sulfacetamide and Neomycin, + Fludrocortisone (veterinary use))
    Laboratoire TVM, France


  • Riacetamid
    Riyad Pharma, Oman


  • S - 40
    Lansier, Peru


  • Solutio Sulfacyli natrii
    Endokriniai, Latvia


  • Sulfacetamida
    Blaskov, Colombia


  • Sulfacyl-Na
    Sanitas, Georgia


  • AK-Sulf
    Akorn, Peru; Akorn, United States


  • Albucid
    Allergan, India; Nicholas, Indonesia


  • Amacin (Sulfacetamide and Neomycin, + Prednisolone, + Polymyxin B sulfate (veterinary use))
    Jurox, Australia


  • Anginamide
    Medgenix, Belgium


  • Antebor
    Kela, Luxembourg; Wolfs, Belgium; Wolfs, Luxembourg


  • Apisulfa
    Amman, Bahrain; Amman Pharmaceutical Industries Co., Oman


  • Aureomix (Sulfacetamide and Chlortetracycline)
    SIT, Italy


  • Blef-10
    Allergan, Colombia; Allergan, Peru


  • Blefamide
    Allergan, Peru


  • Bleph
    Allergan, Australia; Allergan, Bahrain; Allergan, United States


  • Bleph-10
    Allergan, New Zealand; Allergan, United States


  • Blephamide (Sulfacetamide and Prednisolone)
    Allergan, Bahrain; Allergan, Canada; Allergan, Switzerland; Allergan, United States; Pharm Allergan, Germany


  • Brumeton Colloidale S (Sulfacetamide and Betamethasone)
    Bruschettini, Italy


  • Celestone S Coloide (Sulfacetamide and Betamethasone)
    Schering-Plough, Spain


  • Cetamide
    Alcon, United States


  • Cetapred (Sulfacetamide and Prednisolone)
    Alcon, Oman


  • Cetazin
    Sigmapharm, Austria


  • Dermaseb
    Pablo Cassara, Argentina


  • Facetem
    Pascual, Philippines


  • Icid
    Nipa, Bangladesh


  • Isopto Cetamide
    Alcon, Bahrain; Alcon, Botswana; Alcon, Eritrea; Alcon, Ghana; Alcon, Kenya; Alcon, Malawi; Alcon, Namibia; Alcon, Nigeria; Alcon, Tanzania; Alcon, Uganda; Alcon, United States; Alcon, Zambia; Alcon, Zimbabwe


  • Isotic Cetride
    Fahrenheit, Indonesia


  • Klaron
    Dermik, Israel; Sanofi-Aventis, United States


  • Lennon Sulphacetamide
    Aspen Pharmacare Consumer, South Africa


  • Locula
    East India, India


  • Ocusulf
    Miza, United States


  • Oftasul
    Dr. Collado, Dominican Republic


  • Optimide
    Jayson, Bangladesh


  • Optisol
    Fischer, Israel


  • Otenor (Sulfacetamide and Chloramphenicol)
    Rafarm, Greece


  • Paraqueimol
    Aché, Brazil


  • Sivex
    Orva, Turkey


  • Sodium Sulamyd
    Sandoz, Canada


  • Sulf
    Novartis, United States


  • Sulfa 10
    Meda, Belgium


  • Sulfacel
    Optopics, United States


  • Sulfacet
    Oftalmi, Venezuela


  • Sulfacetamid Ofteno
    Sophia, Mexico


  • Sulfacetamida La Santé
    La Santé, Colombia


  • Sulfacetamida Sodica
    Opharm, Colombia


  • Sulfacetamide Sodium 10%
    Perrigo, United States


  • Sulfacetamide Sodium and Prednisolone Sodium Phosphate (Sulfacetamide and Prednisolone disodium phosphate)
    Alcon, United States; Bausch & Lomb, United States; Falcon, United States


  • Sulfacetamide Sodium
    Akorn, United States; Alcon, United States; Bausch & Lomb, United States; Falcon, United States; Fougera, United States; Nycomed, United States; Taro, United States


  • Sulfacetamidum
    Polfa Warszawa, Poland; Polpharma, Poland


  • Sulfacid
    Fischer, Israel


  • Sulfacollyre (Sulfacetamide and Phenylephrine (veterinary use))
    Véto-Centre, France


  • Sulfex
    Xepa-Soul Pattinson, Hong Kong


  • Sulop
    Medifarma, Peru


  • Sulphacetamide-Polpharma
    Polpharma, Czech Republic


  • Vasocidin (Sulfacetamide and Prednisolone)
    Novartis, United States

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 23 July 2010

Rotpunkt Apotheke Mucolyticum




Rotpunkt Apotheke Mucolyticum may be available in the countries listed below.


Ingredient matches for Rotpunkt Apotheke Mucolyticum



Carbocisteine

Carbocisteine is reported as an ingredient of Rotpunkt Apotheke Mucolyticum in the following countries:


  • Switzerland

International Drug Name Search

Forinfec




Forinfec may be available in the countries listed below.


Ingredient matches for Forinfec



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Forinfec in the following countries:


  • Indonesia

International Drug Name Search

Thursday 22 July 2010

CO Terbinafine




CO Terbinafine may be available in the countries listed below.


Ingredient matches for CO Terbinafine



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of CO Terbinafine in the following countries:


  • Canada

International Drug Name Search

Tuesday 20 July 2010

Oksazepam




Oksazepam may be available in the countries listed below.


Ingredient matches for Oksazepam



Oxazepam

Oxazepam is reported as an ingredient of Oksazepam in the following countries:


  • Croatia (Hrvatska)

  • Poland

  • Slovenia

International Drug Name Search

Friday 16 July 2010

Phenylephrine Harvest Pharm




Phenylephrine Harvest Pharm may be available in the countries listed below.


Ingredient matches for Phenylephrine Harvest Pharm



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Phenylephrine Harvest Pharm in the following countries:


  • China

International Drug Name Search

Thursday 15 July 2010

Risperidon Danapha




Risperidon Danapha may be available in the countries listed below.


Ingredient matches for Risperidon Danapha



Risperidone

Risperidone is reported as an ingredient of Risperidon Danapha in the following countries:


  • Vietnam

International Drug Name Search

Tuesday 13 July 2010

Omega-3-acid Ethyl Esters




Scheme

USAN

CAS registry number (Chemical Abstracts Service)

0086227-47-6

Therapeutic Category

Antilipemic agent, concomitant therapy

Chemical Name

Ethyl esters of alpha-linolenic acid (C18:3 n-3), moroctic acid (C18:4 n-3), C20:4 n-3, timnodonic (eicosapentaenoic) acid (C20:5 n-3; EPA), C21:5 n-3, clupanodonic acid (C22:5 n-3) and cervonic (docosahexaenoic) acid (C22:6 n-3; DHA) (Ph. Eur.)

Foreign Names

  • Omega-3 acidorum esteri ethylici (Latin)
  • Omega-3-Säurenethylester (German)
  • Oméga-3 (esters éthyliques d'acides) (French)

Generic Names

  • Omega-3-acid Ethyl Esters (OS: USAN)
  • K 85 (IS)
  • Oméga-3 (esters éthyliques d'acides) (PH: Ph. Eur. 6)
  • Omega-3-Acid Ethyl Esters (PH: Ph. Eur. 6)
  • Omega-3-Acid Ethyl Esters 60 (PH: BP 2010)
  • Omega-3-acid Ethyl Esters 90 (PH: BP 2010)
  • Omega-3-acidorum esteri ethylici (PH: Ph. Eur. 6)
  • Omega-3-Säurenethylester (PH: Ph. Eur. 6)

Brand Names

  • Cardiomega Gold
    Health Signature, Peru


  • Equiplen
    Unimed, Peru


  • Lovaza
    GlaxoSmithKline, United States


  • Marincap
    Koçak, Turkey


  • Maxepa
    Merck, Ecuador; Seven Seas, United Kingdom; Seven Seas, Ireland


  • Omacor
    CPH, Portugal; Euro, Netherlands; Ferrer, Spain; Medcor, Netherlands; Pfizer, Norway; Pierre Fabre Médicament, France; Pronova, Austria; Pronova, Estonia; Pronova, Lithuania; Pronova, Luxembourg; Pronova, Latvia; Pronova, Malta; Pronova, Netherlands; Pronova, Slovenia; Solvay, Belgium; Solvay, Germany; Solvay, United Kingdom; Solvay, Georgia; Solvay, Croatia (Hrvatska); Solvay, Ireland; Solvay, Oman


  • Omecor
    Koçak, Turkey


  • Zodin
    Trommsdorff, Germany

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Eur.European Pharmacopoeia
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 9 July 2010

Aclin




Aclin may be available in the countries listed below.


Ingredient matches for Aclin



Sulindac

Sulindac is reported as an ingredient of Aclin in the following countries:


  • Australia

  • Hong Kong

International Drug Name Search

Saturday 3 July 2010

Furolin




Furolin may be available in the countries listed below.


Ingredient matches for Furolin



Nitrofurantoin

Nitrofurantoin is reported as an ingredient of Furolin in the following countries:


  • Greece

International Drug Name Search

Friday 25 June 2010

Zomepral




Zomepral may be available in the countries listed below.


Ingredient matches for Zomepral



Omeprazole

Omeprazole is reported as an ingredient of Zomepral in the following countries:


  • Chile

Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Zomepral in the following countries:


  • Chile

International Drug Name Search

Thursday 24 June 2010

Oxybutynin Merck NM




Oxybutynin Merck NM may be available in the countries listed below.


Ingredient matches for Oxybutynin Merck NM



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Merck NM in the following countries:


  • Finland

International Drug Name Search

Irritable Bowel Syndrome Medications


Definition of Irritable Bowel Syndrome: A functional bowel disorder characterised by recurrent crampy abdominal pain and diarrhoea. Invasive gastrointestinal diagnostics are often unrevealing.

Drugs associated with Irritable Bowel Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Irritable Bowel Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Irritable Bowel Syndrome





Drug List:

Sunday 20 June 2010

Spasmend




Spasmend may be available in the countries listed below.


Ingredient matches for Spasmend



Mephenesin

Mephenesin is reported as an ingredient of Spasmend in the following countries:


  • South Africa

Paracetamol

Paracetamol is reported as an ingredient of Spasmend in the following countries:


  • South Africa

International Drug Name Search

Wednesday 16 June 2010

Oxaliplatin Ebewe




Oxaliplatin Ebewe may be available in the countries listed below.


Ingredient matches for Oxaliplatin Ebewe



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatin Ebewe in the following countries:


  • Austria

  • Croatia (Hrvatska)

  • Denmark

  • Hungary

  • Malta

  • Netherlands

  • Sweden

  • Tunisia

International Drug Name Search

Monday 14 June 2010

Imusporin Ciclosporina




Imusporin Ciclosporina may be available in the countries listed below.


Ingredient matches for Imusporin Ciclosporina



Ciclosporin

Ciclosporin is reported as an ingredient of Imusporin Ciclosporina in the following countries:


  • Colombia

International Drug Name Search

Wednesday 9 June 2010

Temozolomide




In the US, Temozolomide (temozolomide systemic) is a member of the drug class alkylating agents and is used to treat Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme, Melanoma and Melanoma - Metastatic.

US matches:

  • Temozolomide

  • Temozolomide Intravenous

UK matches:

  • Temozolomide Hospira 100 mg hard capsules. (SPC)
  • Temozolomide Hospira 140 mg hard capsules. (SPC)
  • Temozolomide Hospira 180 mg hard capsules. (SPC)
  • Temozolomide Hospira 20 mg hard capsules. (SPC)
  • Temozolomide Hospira 250 mg hard capsules. (SPC)
  • Temozolomide Hospira 5 mg hard capsules. (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AX03

CAS registry number (Chemical Abstracts Service)

0085622-93-1

Chemical Formula

C6-H6-N6-O2

Molecular Weight

194

Therapeutic Category

Antineoplastic agent, alkylating agent

Chemical Name

Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-

Foreign Names

  • Temozolomidum (Latin)
  • Temozolomid (German)
  • Témozolomide (French)
  • Temozolomida (Spanish)

Generic Names

  • Temozolomide (OS: USAN, BAN)
  • Témozolomide (OS: DCF)
  • BRN 5547136 (IS)
  • CCRG 81045 (IS: Cancer Research C.T.)
  • M & B 39831 (IS: MayBaker)
  • Methazolastone (IS)
  • NSC 362856 (IS)
  • SCH 52365 (IS: ScheringPlough)

Brand Names

  • Dralitem
    Raffo, Argentina


  • Temodal
    Bayer Schering, Iran; Essex, Germany; Essex Chemie, Switzerland; Kirby, Ecuador; Orion, Bulgaria; Schering, United Arab Emirates; Schering, Brazil; Schering, Egypt; Schering, Georgia; Schering, Iraq; Schering, Jordan; Schering, Kuwait; Schering, Lebanon; Schering, Qatar; Schering, Saudi Arabia; Schering, Yemen; Schering-Plough, Argentina; Schering-Plough, Australia; Schering-Plough, Belgium; Schering-Plough, Bulgaria; Schering-Plough, Bahrain; Schering-Plough, Canada; Schering-Plough, Chile; Schering-Plough, Colombia; Schering-Plough, Costa Rica; Schering-Plough, Czech Republic; Schering-Plough, Dominican Republic; Schering-Plough, Spain; Schering-Plough, Finland; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Greece; Schering-Plough, Guatemala; Schering-Plough, Hong Kong; Schering-Plough, Honduras; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Hungary; Schering-Plough, Indonesia; Schering-Plough, Ireland; Schering-Plough, Israel; Schering-Plough, Iceland; Schering-Plough, Japan; Schering-Plough, Luxembourg; Schering-Plough, Mexico; Schering-Plough, Malaysia; Schering-Plough, Nicaragua; Schering-Plough, Netherlands; Schering-Plough, Norway; Schering-Plough, New Zealand; Schering-Plough, Oman; Schering-Plough, Panama; Schering-Plough, Peru; Schering-Plough, Philippines; Schering-Plough, Poland; Schering-Plough, Romania; Schering-Plough, Serbia; Schering-Plough, Russian Federation; Schering-Plough, Sweden; Schering-Plough, Singapore; Schering-Plough, Slovenia; Schering-Plough, Slovakia; Schering-Plough, El Salvador; Schering-Plough, Syria; Schering-Plough, Thailand; Schering-Plough, Turkey; Schering-Plough, Taiwan; Schering-Plough, Venezuela; Schering-Plough, South Africa; SP Europe, Austria; SP Europe, Denmark; SP Europe-B, Italy


  • Temodar
    Schering, United States


  • Temomedac
    Medac, Germany


  • Temozolomid Hexal
    Hexal, Germany


  • Temozolomid Hospira
    Hospira, Germany


  • Temozolomide
    Teva USA, United States

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 6 June 2010

The Time Capusle For Facial Eczema




The Time Capusle For Facial Eczema may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for The Time Capusle For Facial Eczema



Zinc Oxide

Zinc Oxide is reported as an ingredient of The Time Capusle For Facial Eczema in the following countries:


  • New Zealand

International Drug Name Search

Friday 4 June 2010

Omeprazol Cuvefarma




Omeprazol Cuvefarma may be available in the countries listed below.


Ingredient matches for Omeprazol Cuvefarma



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Cuvefarma in the following countries:


  • Spain

International Drug Name Search

Wednesday 26 May 2010

Cypromin




Cypromin may be available in the countries listed below.


Ingredient matches for Cypromin



Cyproheptadine

Cyproheptadine hydrochloride (a derivative of Cyproheptadine) is reported as an ingredient of Cypromin in the following countries:


  • Japan

  • Taiwan

International Drug Name Search

Tuesday 25 May 2010

Chlorocrésol




Chlorocrésol may be available in the countries listed below.


Ingredient matches for Chlorocrésol



Chlorocresol

Chlorocrésol (DCF) is also known as Chlorocresol (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 22 May 2010

Tilidate




Tilidate may be available in the countries listed below.


Ingredient matches for Tilidate



Tilidine

Tilidate (BAN) is also known as Tilidine (Prop.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 16 May 2010

Opilet




Opilet may be available in the countries listed below.


Ingredient matches for Opilet



Azelaic Acid

Azelaic Acid is reported as an ingredient of Opilet in the following countries:


  • Greece

International Drug Name Search

Grisefuline




Grisefuline may be available in the countries listed below.


Ingredient matches for Grisefuline



Griseofulvin

Griseofulvin is reported as an ingredient of Grisefuline in the following countries:


  • Oman

International Drug Name Search

Saturday 15 May 2010

Gastrex




Gastrex may be available in the countries listed below.


Ingredient matches for Gastrex



Dimeticone

Dimeticone is reported as an ingredient of Gastrex in the following countries:


  • Bahrain

  • Oman

Lansoprazole

Lansoprazole is reported as an ingredient of Gastrex in the following countries:


  • Portugal

  • Sweden

International Drug Name Search

Friday 14 May 2010

Biortan




Biortan may be available in the countries listed below.


Ingredient matches for Biortan



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Biortan in the following countries:


  • Venezuela

International Drug Name Search

Wednesday 12 May 2010

Oncotron




Oncotron may be available in the countries listed below.


Ingredient matches for Oncotron



Mitoxantrone

Mitoxantrone is reported as an ingredient of Oncotron in the following countries:


  • India

Mitoxantrone dihydrochloride (a derivative of Mitoxantrone) is reported as an ingredient of Oncotron in the following countries:


  • Latvia

  • Turkey

International Drug Name Search